Spatial Genomics / Scalable Spatial Sequencing Solutions

Spatial Genomics

Resolving complexity with spatial applications in Oncology, Immunology, Developmental Biology, and Pathology

Advance research with full biomarker continuum support and custom assay development

Spatial sequencing is viewing a specific region within a tissue, then sequencing all transcripts found in that region. Spatial sequencing allows for the ability to map variation in gene expression across a tissue or region of interest. Q2 Solutions utilizes leading technologies such as the Nanostring GeoMx® Digital Spatial Profiler (DSP). We can meet your spatial needs with our extensive services spanning the clinical research continuum combined with our global laboratory network and expert support team.

Scalable Spatial Sequencing Solutions 

Nanostring Digital Spatial Profiler (DSP) GeoMx

Spatial Genomics Machine / Nanostring Digital Spatial Profiler (DSP) GeoMx

GeoMx RNA Assays: Profile the whole transcriptome from a single FFPE slide

The GeoMx Human Whole Transcriptome Atlas is designed for comprehensive profiling of spatial biology.
GeoMx® Human Whole Transcriptome Atlas

The GeoMx Human Whole Transcriptome Atlas (GeoMx Hu WTA) is designed for comprehensive profiling of spatial biology.

GeoMx Immune Pathways Panel
GeoMx® Immune Pathways Panel

The GeoMx Immune Pathways Panel is designed for targeted profiling of the tumor, tumor microenvironment, and tumor immune status.

Designed to profile over 1,800 RNA targets simultaneously with spatial resolution.
GeoMx® Cancer Transcriptome Atlas

Designed to profile over 1,800 RNA targets simultaneously with spatial resolution.

GeoMx Protein Assays


The Q2 Solutions team offers:

  1. Full Biomarker Continuum Support
    We are a platform agnostic scientific team with decades of subject matter expertise in utilizing multiple technologies for discovery and validation of biomarkers.

  2. Custom assay development to support hypothesis generating to hypothesis testing stages 
    Our Translational Science and Innovation Laboratory (TSAIL) and Genomics laboratory teams support use of GeoMx DSP for Whole Transcriptome Assessment or targeted proteome interrogation and can support discoveries to cost-efficient methodologies across our global laboratory network.

  3. Scalability 
    Our global footprint and supporting teams allow us to scale to your specific needs

Innovation Laboratories

Q2 Solutions Innovation Laboratory with Spatial Genomics capabilities

Located within our global headquarters in Durham, NC, USA, Q2 Solutions Innovations Laboratories offers the operational alignment necessary for seamless workflows and scientific collaborations due in part to being located in the same geographical location. This team specializes in exploratory and translational biomarker discovery with a focus on new technologies. This alignment of expertise and laboratories is both a unique offering to the field and improves the likelihood of successful project outcomes for large and small endeavors. With scientific thought leaders from anatomic pathology, flow cytometry, genomics, vaccine development, and large molecule bioanalytical services under one roof, Q2 Solutions is well poised to engineer solutions and create novel service offerings for sponsors in support of our mission to turn patients’ hope into the help they need. Learn More.

Related Thought Leaders Insights

Visium Spatial Profiling

Visium spatial profiling is a next-generation sequencing method that enables the analysis of cellular relationships by combining transcriptomics with histological techniques. It has advantages over...

Special Immunoassays Test Menu

This brochure highlights the specialty immunoassays performed by Rules-Based Medicine, a Q2 Solutions company. RBM provides an extensive menu of quantitative protein biomarkers, including multiplexed...

Bridging the LBA and LC−MS disciplines for hybrid assays

The increasing complexity of large molecule therapeutics has driven the need for additional approaches to quantitation in regulated bioanalysis where challenges with traditional ligand binding assays...